
FDA Approves Long-Acting HIV Prevention Drug Amid Access Concerns
A New Option for HIV Prevention The U.S. Food and Drug Administration has approved lenacapavir for pre-exposure prevention of HIV, a move seen as a major step in the fight against the virus. Administered twice a year, the drug offers near-complete protection, according to clinical data released last year. The











